Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Naber, D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Naber, D; Karow, A
      Good tolerability equals good results: the patient's perspective

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    2. Moritz, S; Andresen, B; Jacobsen, D; Mersmann, K; Wilke, U; Lambert, M; Naber, D; Krausz, M
      Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics

      EUROPEAN PSYCHIATRY
    3. Naber, D; Moritz, S; Lambert, M; Rajonk, F; Holzbach, R; Mass, R; Andresen, B; Frank, P; Rudiger, H; Reinhard, M; Burghard, A
      Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    4. Moritz, S; Ruff, C; Wilke, U; Andresen, B; Krausz, M; Naber, D
      Negative priming in schizophrenia: effects of masking and prime presentation time

      SCHIZOPHRENIA RESEARCH
    5. Moritz, S; Mersmann, K; Kloss, M; Jacobsen, D; Andresen, B; Krausz, M; Pawlik, K; Naber, D
      Enhanced semantic priming in thought-disordered schizophrenic patients using a word pronunciation task

      SCHIZOPHRENIA RESEARCH
    6. Moritz, S; Mersmann, K; Kloss, M; Jacobsen, D; Wilke, U; Andresen, B; Naber, D; Pawlik, K
      'Hyper-priming' in thought-disordered schizophrenic patients

      PSYCHOLOGICAL MEDICINE
    7. Moritz, S; Lambert, M; Andresen, B; Bothern, A; Naber, D; Krausz, M
      Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients

      COMPREHENSIVE PSYCHIATRY
    8. Kiefer, F; Jahn, H; Jaschinski, M; Holzbach, R; Wolf, K; Naber, D; Wiedemann, K
      Leptin: A modulator of alcohol craving?

      BIOLOGICAL PSYCHIATRY
    9. Jahn, H; Kellner, M; Naber, D; Wiedemann, K; Kiefer, F
      Leptin as a possible modulator of craving for alcohol

      ARCHIVES OF GENERAL PSYCHIATRY
    10. Altamura, AC; Bobes, J; Owens, DC; Gerlach, J; Hellewell, JSE; Kasper, S; Naber, D; Tarrier, N; Van Os, J
      Schizophrenia: diagnosis and continuing treatment - principles of practicefrom the European expert panel on the contemporary treatment of schizophrenia

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    11. Naber, D; Kasper, S
      The importance of treatment acceptability to patients

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    12. Holzbach, R; Naber, D
      Psychiatric aspects of alcoholism

      CLINICAL NEUROPATHOLOGY
    13. Lambert, M; Haasen, C; Mass, R; Wagner, HB; Moritz, S; Krausz, M; Naber, D
      Correlation between consumption of psychotropic substances and suicidalityamong schizophrenics

      NERVENHEILKUNDE
    14. Pajonk, FG; Holzbach, R; Naber, D
      Evaluation of efficacy of neuroleptics in open versus double-blind trials:objective

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    15. Krausz, M; Moritz, S; Lambert, M; Naber, D
      Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    16. Naber, D
      Long-term phase of schizophrenia: impact of atypical agents

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    17. Moritz, S; Krausz, M; Gottwalz, E; Lambert, M; Perro, C; Ganzer, S; Naber, D
      Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics

      PSYCHOPATHOLOGY
    18. Moritz, S; Andresen, B; Probsthein, E; Martin, T; Domin, F; Kretschmer, G; Krausz, M; Lambert, M; Naber, D
      Stimulus onset asynchronicity as a modulator of negative priming in schizotypy

      PERSONALITY AND INDIVIDUAL DIFFERENCES
    19. Naber, D
      Atypical antipsychotics

      NERVENARZT
    20. Lambert, M; Moritz, S; Haasen, C; Naber, D
      Conversion from conventional to atypical neuroleptics - recommendations for inpatient and outpatient treatment

      NERVENARZT
    21. Krausz, M; Moritz, SH; Naber, D; Lambert, M; Andresen, B
      Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia

      EUROPEAN PSYCHIATRY
    22. Lambert, M; Naber, D; Perro, C; Moritz, S; Krausz, M
      Opportunities for new treatments of schizophrenia - Modern antipsychotic medication

      PSYCHIATRISCHE PRAXIS
    23. Naber, D
      Optimizing clozapine treatment

      JOURNAL OF CLINICAL PSYCHIATRY
    24. Moritz, S; Andresen, B; Domin, F; Martin, T; Probsthein, E; Kretschmer, G; Krausz, M; Naber, D; Spitzer, M
      Increased automatic spreading activation in healthy subjects with elevatedscores in a scale assessing schizophrenic language disturbances

      PSYCHOLOGICAL MEDICINE
    25. Dittert, S; Naber, D; Soyka, M
      Methadone substitution and ability to drive. Results of an experimental study

      NERVENARZT
    26. Krausz, M; Raschke, P; Naber, D
      Methodone maintenance for heroin addicts

      INTERNIST
    27. LABELLE A; DEBEAUREPAIRE R; BOULAY LJ; NABER D; JONES BD; BARNES TRE
      A PILOT-STUDY OF THE SAFETY AND TOLERANCE OF SCH-39166 IN PATIENTS WITH SCHIZOPHRENIA

      Journal of psychiatry & neuroscience
    28. PAJONK FG; NABER D
      HUMAN-IMMUNODEFICIENCY-VIRUS AND MENTAL-DISORDERS

      Current opinion in psychiatry
    29. NABER D
      SUBJECTIVE EXPERIENCES OF SCHIZOPHRENIC-PATIENTS TREATED WITH ANTIPSYCHOTIC MEDICATION

      International clinical psychopharmacology
    30. FINCKH U; MANN U; MULLERTHOMSEN T; EGGERS C; NABER D; NITSCH RM; GAL A
      UNEXPECTED SPECTRUM OF DISEASE-CAUSING MUTATIONS IN A CLINICAL-SAMPLEOF PATIENTS WITH PRESENILE-DEMENTIA

      American journal of medical genetics
    31. GROWDON J; DENG A; THOMSEN TM; MANN U; BUHMANN J; STURENBURG HJ; EGGERS C; LANGER U; VELDEN J; VONDERKAMMER H; WIEGMANN H; KUNZE S; NABER D; REBECK B; SCHOENFELD D; HOCK C; NITSCH R
      CEREBROSPINAL-FLUID LEVELS OF A NOVEL PRESENILIN LOOP FRAGMENT ARE INCREASED IN ALZHEIMERS-DISEASE

      Neurology
    32. PETER H; STARK FM; LAUTERBACH B; NABER D
      SYNERGISTIC EFFECTS BETWEEN BEHAVIOR-THERAPY AND SSRI TREATMENT - A CASE-REPORT OF A PATIENT WITH TREATMENT-RESISTANT DEPRESSION

      Verhaltenstherapie
    33. RIETSCHEL M; NABER D; FIMMERS R; MOLLER HJ; PROPPING P; NOTHEN MM
      EFFICACY AND SIDE-EFFECTS OF CLOZAPINE NOT ASSOCIATED WITH VARIATION IN THE 5-HT2C RECEPTOR

      NeuroReport
    34. SOYKA M; BANZER K; BUCHBERGER R; VOLKL M; NABER D
      METHADONE-MAINTENANCE THERAPY IN OPIOID D EPENDENCE

      Nervenheilkunde
    35. RIETSCHEL M; KRAUSS H; FERNANDEZ ANY; MAIER W; NABER D; MOLLER HJ; PROPPING P; NOTHEN MM
      WEIGHT-GAIN AND EEG ALTERATIONS UNDER TREATMENT WITH CLOZAPINE NOT ASSOCIATED WITH 5-HT2C VARIANTS

      American journal of medical genetics
    36. NABER D; KIRCHER T; HESSEL K
      SCHIZOPHRENIC-PATIENTS RETROSPECTIVE ATTITUDES REGARDING INVOLUNTARY PSYCHOPHARMACOLOGICAL TREATMENT AND RESTRAINT

      European psychiatry
    37. LABELLE A; DEBEAUREPAIRE R; BOULAY LJ; JONES BD; NABER D; BARNES TRE
      EFFICACY, SAFETY AND TOLERANCE OF A D-1 ANTAGONIST SCH-3966 IN 6 CASES OF ACUTE PSYCHOTIC STATES

      Schizophrenia research
    38. RIETSCHEL M; NABER D; OBERLANDER H; HOLZBACH R; FIMMERS R; EGGERMANN K; MOLLER HJ; PROPPING P; NOTHEN MM
      EFFICACY AND SIDE-EFFECTS OF CLOZAPINE - TESTING FOR ASSOCIATION WITHALLELIC VARIATION IN THE DOPAMINE D-4 RECEPTOR GENE

      Neuropsychopharmacology
    39. NABER D; SAND P; HEIGL B
      PSYCHOPATHOLOGICAL AND NEUROPSYCHOLOGICAL EFFECTS OF 8-DAYS CORTICOSTEROID TREATMENT - A PROSPECTIVE-STUDY

      Psychoneuroendocrinology
    40. MODELL S; NABER D; HOLZBACH R
      EFFICACY AND SAFETY OF AN OPIATE SIGMA-RECEPTOR ANTAGONIST (SL-82.0715) IN SCHIZOPHRENIC-PATIENTS WITH NEGATIVE SYMPTOMS - AN OPEN DOSE-RANGE STUDY

      Pharmacopsychiatry
    41. SOYKA M; HOLLWEG M; NABER D
      ALCOHOL DEPENDENCE AND DEPRESSION - CLASS IFICATION, COMORBIDITY, GENETIC AND NEUROBIOLOGICAL ASPECTS

      Nervenarzt
    42. NABER D
      A SELF-RATING TO MEASURE SUBJECTIVE EFFECTS OF NEUROLEPTIC DRUGS, RELATIONSHIPS TO OBJECTIVE PSYCHOPATHOLOGY, QUALITY-OF-LIFE, COMPLIANCE AND OTHER CLINICAL-VARIABLES

      International clinical psychopharmacology
    43. NOTHEN MM; RIETSCHEL M; ERDMANN J; OBERLANDER H; MOLLER HJ; NABER D; PROPPING P
      GENETIC-VARIATION OF THE 5-HT2A RECEPTOR AND RESPONSE TO CLOZAPINE

      Lancet
    44. ZARATE CA; DANIEL DG; KINON BJ; LITMAN RE; NABER D; PICKAR D; SATO M
      INTERNATIONAL PSYCHOPHARMACOLOGY ALGORITHM PROJECT REPORT .A. ALGORITHMS FOR THE TREATMENT OF SCHIZOPHRENIA

      Psychopharmacology bulletin
    45. NIEDERECKER M; NABER D; RIEDEL R; PERRO C; GOEBEL FD
      FREQUENCY AND ETIOLOGY OF PSYCHOSES IN HI V-INFECTED PATIENTS

      Nervenarzt
    46. DEBEAUREPAIRE R; LABELLE A; NABER D; JONES BD; BARNES TRE
      AN OPEN TRIAL OF THE D-1 ANTAGONIST SCH-39166 IN 6 CASES OF ACUTE PSYCHOTIC STATES

      Psychopharmacology
    47. KATHMANN N; KUISLE U; BOMMER M; NABER D; MULLER OA; ENGEL RR
      EFFECTS OF ELEVATED TRIIODOTHYRONINE ON COGNITIVE PERFORMANCE AND MOOD IN HEALTHY-SUBJECTS

      Neuropsychobiology
    48. NABER D
      TREATMENT OF DRUG-ADDICTS AT A GENERAL-HO SPITAL

      Der Internist
    49. MAJ M; SATZ P; JANSSEN R; ZAUDIG M; STARACE F; DELIA L; SUGHONDHABIROM B; MUSSA M; NABER D; NDETEI D; SCHULTE G; SARTORIUS N
      WHO NEUROPSYCHIATRIC AIDS STUDY, CROSS-SECTIONAL PHASE-II - NEUROPSYCHOLOGICAL AND NEUROLOGICAL FINDINGS

      Archives of general psychiatry
    50. NABER D; PAJONK FG; PERRO C; LOHMER B
      HUMAN-IMMUNODEFICIENCY-VIRUS ANTIBODY-TEST AND SEROPREVALENCE IN PSYCHIATRIC-PATIENTS

      Acta psychiatrica Scandinavica
    51. PERRO C; GEIER SA; NABER D; KLAUSS V; KRONAWITTER U; BOGNER JR; GOEBEL ED
      HIV-RELATED OCULAR MICROANGIOPATHIC SYNDROME AND NEUROPSYCHOLOGICAL FUNCTIONING

      AIDS
    52. GUNTHER W; BAGHAI T; NABER D; SPATZ R; HIPPIUS H
      EEG ALTERATIONS AND SEIZURES DURING TREATMENT WITH CLOZAPINE - A RETROSPECTIVE STUDY OF 283 PATIENTS

      Pharmacopsychiatry
    53. MODELL S; NABER D; MULLERSPAHN F
      PARANOID PSYCHOSIS IN A PATIENT WITH HYPOTHYROIDISM AND VITAMIN-B(12)DEFICIENCY

      Nervenarzt
    54. PERRO C; NABER D; LOHMER B; HAMMEL G
      HIV TESTING AND SEROPREVALENCE AMONG PSYCHIATRIC-INPATIENTS

      Nervenarzt
    55. SCHWENGERERGER C; THIEMANN J; BARZ W; JOHANNINGMEIER U; NABER D
      METRIBUZIN RESISTANCE IN PHOTOAUTOTROPHIC CHENOPODIUM-RUBRUM CELL-CULTURES - CHARACTERIZATION OF DOUBLE AND TRIPLE MUTATIONS IN THE PSBA GENE

      FEBS letters
    56. MAYER C; KELTERBORN G; NABER D
      AGE OF ONSET IN SCHIZOPHRENIA - RELATIONS TO PSYCHOPATHOLOGY AND GENDER

      British Journal of Psychiatry
    57. NABER D; BOMMER M
      SUBCLINICAL HYPOTHYROIDISM IN RECURRENT MANIA - RESPONSE

      Biological psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 03:47:07